Adaptive Biotechnologies (ADPT) Competitors $12.54 +0.85 (+7.27%) Closing price 08/7/2025 04:00 PM EasternExtended Trading$12.58 +0.04 (+0.28%) As of 08/7/2025 07:48 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ADPT vs. TWST, TXG, VCYT, TGTX, NUVL, CRSP, RYTM, LNTH, AXSM, and TLXShould you be buying Adaptive Biotechnologies stock or one of its competitors? The main competitors of Adaptive Biotechnologies include Twist Bioscience (TWST), 10x Genomics (TXG), Veracyte (VCYT), TG Therapeutics (TGTX), Nuvalent (NUVL), CRISPR Therapeutics (CRSP), Rhythm Pharmaceuticals (RYTM), Lantheus (LNTH), Axsome Therapeutics (AXSM), and Telix Pharmaceuticals (TLX). These companies are all part of the "medical" sector. Adaptive Biotechnologies vs. Its Competitors Twist Bioscience 10x Genomics Veracyte TG Therapeutics Nuvalent CRISPR Therapeutics Rhythm Pharmaceuticals Lantheus Axsome Therapeutics Telix Pharmaceuticals Twist Bioscience (NASDAQ:TWST) and Adaptive Biotechnologies (NASDAQ:ADPT) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, risk, earnings, dividends, media sentiment, analyst recommendations, institutional ownership and profitability. Does the media favor TWST or ADPT? In the previous week, Twist Bioscience had 8 more articles in the media than Adaptive Biotechnologies. MarketBeat recorded 24 mentions for Twist Bioscience and 16 mentions for Adaptive Biotechnologies. Adaptive Biotechnologies' average media sentiment score of 0.61 beat Twist Bioscience's score of 0.50 indicating that Adaptive Biotechnologies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Twist Bioscience 5 Very Positive mention(s) 2 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 2 Very Negative mention(s) Positive Adaptive Biotechnologies 4 Very Positive mention(s) 1 Positive mention(s) 6 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Is TWST or ADPT more profitable? Twist Bioscience has a net margin of -23.51% compared to Adaptive Biotechnologies' net margin of -59.07%. Twist Bioscience's return on equity of -29.03% beat Adaptive Biotechnologies' return on equity.Company Net Margins Return on Equity Return on Assets Twist Bioscience-23.51% -29.03% -21.77% Adaptive Biotechnologies -59.07%-60.93%-23.03% Do institutionals and insiders hold more shares of TWST or ADPT? 99.2% of Adaptive Biotechnologies shares are held by institutional investors. 3.0% of Twist Bioscience shares are held by company insiders. Comparatively, 6.4% of Adaptive Biotechnologies shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Which has better earnings & valuation, TWST or ADPT? Adaptive Biotechnologies has lower revenue, but higher earnings than Twist Bioscience. Twist Bioscience is trading at a lower price-to-earnings ratio than Adaptive Biotechnologies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTwist Bioscience$312.97M4.82-$208.73M-$1.45-17.24Adaptive Biotechnologies$178.96M10.67-$159.49M-$0.82-15.29 Which has more volatility and risk, TWST or ADPT? Twist Bioscience has a beta of 2.36, meaning that its share price is 136% more volatile than the S&P 500. Comparatively, Adaptive Biotechnologies has a beta of 1.92, meaning that its share price is 92% more volatile than the S&P 500. Do analysts prefer TWST or ADPT? Twist Bioscience currently has a consensus price target of $49.40, indicating a potential upside of 97.60%. Adaptive Biotechnologies has a consensus price target of $12.38, indicating a potential downside of 1.32%. Given Twist Bioscience's higher probable upside, analysts plainly believe Twist Bioscience is more favorable than Adaptive Biotechnologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Twist Bioscience 1 Sell rating(s) 1 Hold rating(s) 9 Buy rating(s) 0 Strong Buy rating(s) 2.73Adaptive Biotechnologies 0 Sell rating(s) 1 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.88 SummaryTwist Bioscience and Adaptive Biotechnologies tied by winning 8 of the 16 factors compared between the two stocks. Get Adaptive Biotechnologies News Delivered to You Automatically Sign up to receive the latest news and ratings for ADPT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ADPT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ADPT vs. The Competition Export to ExcelMetricAdaptive BiotechnologiesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.78B$2.98B$5.48B$9.57BDividend YieldN/A2.46%3.99%4.17%P/E Ratio-15.2917.9729.8525.14Price / Sales10.67262.52422.3397.16Price / CashN/A41.8335.9458.58Price / Book10.637.238.125.59Net Income-$159.49M-$54.43M$3.26B$265.48M7 Day Performance21.39%0.22%0.68%1.22%1 Month Performance6.81%5.59%2.46%0.39%1 Year Performance185.00%9.98%27.99%23.47% Adaptive Biotechnologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ADPTAdaptive Biotechnologies2.9894 of 5 stars$12.54+7.3%$12.38-1.3%+199.3%$1.78B$178.96M-15.29790Trending NewsEarnings ReportAnalyst ForecastHigh Trading VolumeTWSTTwist Bioscience3.5472 of 5 stars$36.53+1.5%$50.40+38.0%-43.9%$2.16B$312.97M-11.24990Earnings ReportAnalyst RevisionTXG10x Genomics3.8119 of 5 stars$14.64+3.8%$13.23-9.6%-29.4%$1.74B$610.78M-11.261,240Trending NewsEarnings ReportGap UpVCYTVeracyte2.6991 of 5 stars$25.02-0.9%$40.90+63.5%+2.3%$1.98B$445.76M61.03790Trending NewsGap UpHigh Trading VolumeTGTXTG Therapeutics4.0201 of 5 stars$35.99-2.5%$43.80+21.7%+39.5%$5.86B$329M149.96290Trending NewsEarnings ReportAnalyst RevisionNUVLNuvalent3.1474 of 5 stars$81.94+0.7%$119.60+46.0%+7.0%$5.85BN/A-18.6740Upcoming EarningsCRSPCRISPR Therapeutics3.6797 of 5 stars$63.75-1.6%$71.31+11.9%+18.4%$5.59B$37.31M-14.10460Trending NewsEarnings ReportAnalyst ForecastAnalyst RevisionRYTMRhythm Pharmaceuticals3.5698 of 5 stars$85.68-0.9%$91.93+7.3%+112.3%$5.50B$130.13M-30.49140Earnings ReportAnalyst ForecastLNTHLantheus4.6129 of 5 stars$72.41-0.7%$131.20+81.2%-42.9%$5.05B$1.53B20.57700Trending NewsEarnings ReportAnalyst ForecastAXSMAxsome Therapeutics4.8393 of 5 stars$100.39-0.4%$172.33+71.7%+24.4%$4.96B$385.69M-17.40380Trending NewsEarnings ReportAnalyst ForecastAnalyst RevisionTLXTelix PharmaceuticalsN/A$13.96-1.7%$22.33+60.0%N/A$4.81B$516.72M0.00N/A Related Companies and Tools Related Companies Twist Bioscience Competitors 10x Genomics Competitors Veracyte Competitors TG Therapeutics Competitors Nuvalent Competitors CRISPR Therapeutics Competitors Rhythm Pharmaceuticals Competitors Lantheus Competitors Axsome Therapeutics Competitors Telix Pharmaceuticals Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ADPT) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredCritical AI announcement set to ignite AI 2.0 A new 100% tariff on imported chips just rattled the tech sector—sending some stocks soaring and others tumbli...Timothy Sykes | SponsoredTrump’s new nightmareAccording to Porter Stansberry and Jeff Brown, a government-led financial mobilization is already reshaping Am...Porter & Company | SponsoredThe Day Silicon DiesThe Day China Left America's Supercomputers in the Dust In 200 seconds, China's quantum computer accomplish...The Oxford Club | SponsoredThis accelerated income plan is solving American's #1 retirement fearThe #1 fear in retirement today? Running out of money. That’s why income expert Tim Plaehn created a simple...Investors Alley | SponsoredSell this, buy thatWhat you don’t own matters just as much as what you do. That’s the thinking behind Eric Fry’s long-time strate...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Adaptive Biotechnologies Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Adaptive Biotechnologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ADPT Stock Alerts